ATS/SMITH & NEPHEW $20 MIL VENTURE FOR JOINT REPAIR
This article was originally published in The Gray Sheet
Executive Summary
ATS/SMITH & NEPHEW $20 MIL VENTURE FOR JOINT REPAIR initially will focus on developing human tissue engineered cartilage for repair of damaged articular cartilage in knee joints. Should ongoing pre-clinical development proceed according to schedule, the product could be in human clinicals by the second half of 1995. Under the agreement, announced May 9, the two companies will "enter into a 50/50 joint venture for the worldwide development, manufacture and marketing of human tissue for orthopedic applications."